{
    "ticker": "LVHD",
    "name": "LivaNova PLC",
    "description": "LivaNova PLC is a global medical technology company focused on delivering innovative solutions for patients with cardiovascular and neuromodulation conditions. Established in 2015 through the merger of the cardiovascular division of Sorin Group and the neuromodulation division of Cyberonics, LivaNova aims to improve the lives of patients worldwide. The company operates through two primary business segments: Cardiovascular and Neuromodulation. In the Cardiovascular segment, LivaNova provides advanced technologies for cardiac surgery, including heart-lung machines, perfusion systems, and a range of valve products. The Neuromodulation segment focuses on innovative therapies for epilepsy and depression, featuring the VNS Therapy System, which offers life-changing treatment options for patients suffering from these conditions. With a commitment to research and development, LivaNova actively invests in cutting-edge technologies and clinical studies to enhance patient outcomes. The company operates in over 100 countries and is dedicated to addressing unmet medical needs through its comprehensive product portfolio and patient-centric approach. LivaNova's mission is to advance patient care and improve quality of life through innovative medical solutions.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "London, United Kingdom",
    "founded": "2015",
    "website": "https://www.livanova.com",
    "ceo": "Damien McDonald",
    "social_media": {
        "twitter": "https://twitter.com/LivaNova",
        "linkedin": "https://www.linkedin.com/company/livanova/"
    },
    "investor_relations": "https://investors.livanova.com",
    "key_executives": [
        {
            "name": "Damien McDonald",
            "position": "CEO"
        },
        {
            "name": "Vikram A. Ghosh",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cardiovascular",
            "products": [
                "Heart-Lung Machines",
                "Perfusion Systems",
                "Valves"
            ]
        },
        {
            "category": "Neuromodulation",
            "products": [
                "VNS Therapy System"
            ]
        }
    ],
    "seo": {
        "meta_title": "LivaNova PLC | Innovative Medical Solutions for Patients",
        "meta_description": "Discover LivaNova PLC, a leader in medical technology dedicated to improving patient care through innovative cardiovascular and neuromodulation solutions.",
        "keywords": [
            "LivaNova",
            "Medical Devices",
            "Neuromodulation",
            "Cardiovascular",
            "VNS Therapy",
            "Patient Care"
        ]
    },
    "faq": [
        {
            "question": "What does LivaNova specialize in?",
            "answer": "LivaNova specializes in medical technology for cardiovascular and neuromodulation conditions."
        },
        {
            "question": "Who is the CEO of LivaNova?",
            "answer": "Damien McDonald is the CEO of LivaNova PLC."
        },
        {
            "question": "Where is LivaNova headquartered?",
            "answer": "LivaNova is headquartered in London, United Kingdom."
        },
        {
            "question": "What are LivaNova's main products?",
            "answer": "LivaNova's main products include heart-lung machines, perfusion systems, valves, and the VNS Therapy System."
        },
        {
            "question": "When was LivaNova founded?",
            "answer": "LivaNova was founded in 2015."
        }
    ],
    "competitors": [
        "SYK",
        "MDT",
        "ZBH",
        "ABT"
    ],
    "related_stocks": [
        "JNJ",
        "BAX",
        "RMD",
        "ISRG"
    ]
}